Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$60.1B
▲ 1.4% vs FY2022 ($59.3B)
Net Income: $365M
Source: 10-K
Merck & Co., Inc. reported $60.1B in revenue for fiscal year 2023. This represents a growth of 1.4% compared to the 2022 figure of $59.3B. In 2024, revenue increased to $63.6B.
Revenue rose about 1.4 percent to roughly 60.1 billion USD, a slower advance as the abrupt Gardasil procurement pullback in China weighed on the vaccine franchise.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $65.0B | — | +2.2% |
| FY2024 | $63.6B | $17.1B | +5.8% |
| FY2023 | $60.1B | $365M | +1.4% |
| FY2022 | $59.3B | $14.5B | +21.7% |
| FY2021 | $48.7B | $13.0B | +1.5% |
| FY2020 | $48.0B | $7.1B | +2.5% |
| FY2019 | $46.8B | $9.8B | +10.7% |
| FY2018 | $42.3B | $6.2B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.